Endothelin receptor antagonist bosentan improves the dermal sclerosis in a patient with systemic sclerosis

被引：3
|
作者：
Nishibu, Akiko [1 ,2 ]
Sakai, Erika [1 ]
Oyama, Noritaka [1 ]
Yamamoto, Toshiyuki [1 ]
机构：
[1] Fukushima Med Univ, Dept Dermatol, Fukushima, Japan
[2] Kanazawa Med Univ, Dept Dermatol, Kanazawa, Ishikawa, Japan
来源：
AUSTRALASIAN JOURNAL OF DERMATOLOGY | 2012年 / 53卷 / 02期
关键词：
bosentan; endothelin; systemic sclerosis; DIGITAL ULCERS;
D O I：
10.1111/j.1440-0960.2010.00719.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
We report a case of systemic sclerosis with interstitial pneumonia and severe pulmonary hypertension treated with bosentan, an endothelin receptor antagonist. Within a short period of administration of the bosentan the skin sclerosis improved.
引用
收藏
页码：E32 / E33
页数：2
相关论文
共 50 条
  • [21] Bosentan For Digital Ulcers in Patients With Systemic Sclerosis: Single Center Experience
    Kucuksahin, Orhan
    Yildizgoren, Mustafa Turgut
    Gerede, Demet Menekse
    Maras, Yuksel
    Erten, Sukran
    ARCHIVES OF RHEUMATOLOGY, 2016, 31 (03): : 229 - 233
  • [22] Autoantibodies against Endothelin 1 Type A Receptor Are Strong Predictors of Digital Ulcers in Systemic Sclerosis
    Avouac, Jerome
    Riemekasten, Gabriela
    Meune, Christophe
    Ruiz, Barbara
    Kahan, Andre
    Allanore, Yannick
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (10) : 1801 - 1807
  • [23] Bosentan fosters microvascular de-remodelling in systemic sclerosis
    S. Guiducci
    S. Bellando Randone
    C. Bruni
    G. Carnesecchi
    A. Maresta
    F. Iannone
    G. Lapadula
    M. Matucci Cerinic
    Clinical Rheumatology, 2012, 31 : 1723 - 1725
  • [24] Endothelin may be pathogenic in systemic sclerosis of the heart
    Kazzam, E
    Waldenstrom, A
    Hedner, T
    Hedner, J
    Caidahl, K
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1997, 60 (01) : 31 - 39
  • [25] No effects of bosentan on microvasculature in patients with limited cutaneous systemic sclerosis
    Martha E. Hettema
    Dan Zhang
    Ymkje Stienstra
    Andries J. Smit
    Hendrika Bootsma
    Cees G. M. Kallenberg
    Clinical Rheumatology, 2009, 28 : 825 - 833
  • [26] No effects of bosentan on microvasculature in patients with limited cutaneous systemic sclerosis
    Hettema, Martha E.
    Zhang, Dan
    Stienstra, Ymkje
    Smit, Andries J.
    Bootsma, Hendrika
    Kallenberg, Cees G. M.
    CLINICAL RHEUMATOLOGY, 2009, 28 (07) : 825 - 833
  • [27] Bosentan fosters microvascular de-remodelling in systemic sclerosis
    Guiducci, S.
    Randone, S. Bellando
    Bruni, C.
    Carnesecchi, G.
    Maresta, A.
    Iannone, F.
    Lapadula, G.
    Cerinic, M. Matucci
    CLINICAL RHEUMATOLOGY, 2012, 31 (12) : 1723 - 1725
  • [28] Longterm Effects of Endothelin Receptor Antagonism on Microvascular Damage Evaluated by Nailfold Capillaroscopic Analysis in Systemic Sclerosis
    Cutolo, Maurizio
    Zampogna, Giuseppe
    Vremis, Laura
    Smith, Vanessa
    Pizzorni, Carmen
    Sulli, Alberto
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (01) : 40 - 45
  • [29] Combination therapy with Bosentan and Sildenafil improves Raynaud’s phenomenon and fosters the recovery of microvascular involvement in systemic sclerosis
    S. Bellando-Randone
    G. Lepri
    C. Bruni
    J. Blagojevic
    A. Radicati
    L. Cometi
    A. De Paulis
    M. Matucci-Cerinic
    S. Guiducci
    Clinical Rheumatology, 2016, 35 : 127 - 132
  • [30] THE EFFECT OF BOSENTAN, A NEW POTENT ENDOTHELIN RECEPTOR ANTAGONIST, ON THE PATHOGENESIS OF CEREBRAL VASOSPASM
    SHIGENO, T
    CLOZEL, M
    SAKAI, S
    SAITO, A
    GOTO, K
    NEUROSURGERY, 1995, 37 (01) : 87 - 90
12345